XML 22 R43.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Guarantor Information (Details) (USD $)
In Millions, unless otherwise specified
 3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Dec. 31, 2013
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income          
Revenue $ 319.9 $ 312.0 $ 642.4 $ 637.7  
Operating costs and expenses 284.3 265.2 549.9 571.7  
Operating (loss) income 35.6 46.8 92.5 66.0  
Interest expense (income), net 40.7 45.4 81.0 93.3  
Other (income) expense, net 0.1 0.1 0.7 (0.2)  
Income (loss) before equity in earnings of subsidiaries and income taxes 185.2 (3.4) 201.7 (33.7)  
Income tax expense (benefit) 71.0 (4.2) 80.5 2.2  
Net income (loss) 114.2 0.8 121.2 (35.9)  
Total comprehensive income (loss) 114.8 9.8 123.6 (24.3)  
Preferred stock dividends 2.6 2.6 5.2 5.2  
Net income (loss) applicable to common shareowners 111.6 (1.8) 116.0 (41.1)  
Condensed Consolidating Balance Sheets          
Cash and cash equivalents 347.2 5.5 347.2 5.5  
Other current assets 0.7   0.7   1.6
Total current assets 608.3   608.3   251.1
Property, plant and equipment, net 874.7   874.7   902.8
Investment in CyrusOne 290.7   290.7   471.0
Other noncurrent assets 38.8   38.8   36.6
Total assets 2,176.9   2,176.9   2,107.3
Current portion of long-term debt 12.1   12.1   12.6
Accounts payable 105.1   105.1   89.4
Other current liabilities 36.2   36.2   36.8
Total current liabilities 270.6   270.6   254.3
Long-term debt, less current portion 2,214.2   2,214.2   2,252.6
Other noncurrent liabilities 62.7   62.7   74.4
Total liabilities 2,732.9   2,732.9   2,784.0
Shareowners' (deficit) equity (556.0)   (556.0)   (676.7)
Total liabilities and shareowners' equity (deficit) 2,176.9   2,176.9   2,107.3
Condensed Consolidating Statements of Cash Flows          
Cash flows (used in) provided by operating activities     93.8 29.4  
Capital expenditures (41.2) (45.0) (75.5) (95.9)  
Proceeds from Sale of CyrusOne     355.9 0  
Dividends received from CyrusOne 9.3   16.4 7.0  
Proceeds from sale of assets     2.0 1.6  
Cash divested from deconsolidation of CyrusOne     0 (12.2)  
Other investing activities     (5.7) 0  
Cash flows used in investing activities     293.1 (99.1)  
Borrowings on revolving facilities, net     (31.4) 56.8  
Repayment of debt     (8.3) (4.8)  
Proceeds from exercise of options and warrants     1.2 6.6  
Other financing activities     (1.4) (2.3)  
Cash flows provided by (used in) financing activities     (44.3) 51.6  
(Decrease) increase in cash and cash equivalents     342.6 (18.1)  
Cash and cash equivalents at beginning of period     4.6 23.6  
Cash and cash equivalents at end of period 347.2 5.5 347.2 5.5  
Notes guaranteed by parent [Member]
          
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income          
Revenue 319.9 312.0 642.4 637.7  
Operating costs and expenses 284.3 265.2 549.9 571.7  
Operating (loss) income 35.6 46.8 92.5 66.0  
Interest expense (income), net 40.7 45.4 81.0 93.3  
Other (income) expense, net (190.3) 4.8 (190.2) 6.4  
Income (loss) before equity in earnings of subsidiaries and income taxes 185.2 (3.4) 201.7 (33.7)  
Income tax expense (benefit) 71.0 (4.2) 80.5 2.2  
Equity in earnings of subsidiaries, net of tax 0 0 0 0  
Net income (loss) 114.2 0.8 121.2 (35.9)  
Other comprehensive income (loss) 0.6 9.0 2.4 11.6  
Total comprehensive income (loss) 114.8 9.8 123.6 (24.3)  
Preferred stock dividends 2.6 2.6 5.2 5.2  
Net income (loss) applicable to common shareowners 111.6 (1.8) 116.0 (41.1)  
Condensed Consolidating Balance Sheets          
Cash and cash equivalents 347.2 5.5 347.2 5.5  
Receivables, net 170.0   170.0   154.8
Other current assets 91.1   91.1   91.7
Total current assets 608.3   608.3   251.1
Property, plant and equipment, net 874.7   874.7   902.8
Investment in CyrusOne 290.7   290.7   471.0
Goodwill and intangibles, net 104.9   104.9   106.1
Investments in and advances to subsidiaries 0   0   0
Other noncurrent assets 298.3   298.3   376.3
Total assets 2,176.9   2,176.9   2,107.3
Current portion of long-term debt 12.1   12.1   12.6
Accounts payable 105.4   105.4   89.9
Other current liabilities 153.1   153.1   151.8
Total current liabilities 270.6   270.6   254.3
Long-term debt, less current portion 2,214.2   2,214.2   2,252.6
Other noncurrent liabilities 248.1   248.1   277.1
Intercompany payables 0   0   0
Total liabilities 2,732.9   2,732.9   2,784.0
Shareowners' (deficit) equity (556.0)   (556.0)   (676.7)
Total liabilities and shareowners' equity (deficit) 2,176.9   2,176.9   2,107.3
Condensed Consolidating Statements of Cash Flows          
Cash flows (used in) provided by operating activities     93.8 29.4  
Capital expenditures     (75.5) (95.9)  
Proceeds from Sale of CyrusOne     355.9    
Dividends received from CyrusOne     16.4 7.0  
Proceeds from sale of assets     2.0 1.6  
Cash divested from deconsolidation of CyrusOne       (12.2)  
Other investing activities     (5.7) 0.4  
Cash flows used in investing activities     293.1 (99.1)  
Funding between Parent and subsidiaries, net     0 0  
Borrowings on revolving facilities, net     (31.4) 56.8  
Repayment of debt     (8.3) (4.8)  
Proceeds from exercise of options and warrants     1.2 6.6  
Other financing activities     (5.8) (7.0)  
Cash flows provided by (used in) financing activities     (44.3) 51.6  
(Decrease) increase in cash and cash equivalents     342.6 (18.1)  
Cash and cash equivalents at beginning of period     4.6 23.6  
Cash and cash equivalents at end of period 347.2 5.5 347.2 5.5  
Notes guaranteed by parent [Member] | Parent Company [Member]
          
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income          
Revenue 0 0 0 0  
Operating costs and expenses 4.8 13.6 10.9 49.7  
Operating (loss) income (4.8) (13.6) (10.9) (49.7)  
Interest expense (income), net 37.9 46.3 75.0 82.1  
Other (income) expense, net (0.4) (0.3) (0.7) (0.7)  
Income (loss) before equity in earnings of subsidiaries and income taxes (42.3) (59.6) (85.2) (131.1)  
Income tax expense (benefit) (11.0) (21.2) (22.5) (41.3)  
Equity in earnings of subsidiaries, net of tax 145.5 39.2 183.9 53.9  
Net income (loss) 114.2 0.8 121.2 (35.9)  
Other comprehensive income (loss) 0.6 8.9 2.4 11.7  
Total comprehensive income (loss) 114.8 9.7 123.6 (24.2)  
Preferred stock dividends 2.6 2.6 5.2 5.2  
Net income (loss) applicable to common shareowners 111.6 (1.8) 116.0 (41.1)  
Condensed Consolidating Balance Sheets          
Cash and cash equivalents 344.3 3.3 344.3 3.3  
Receivables, net 2.0   2.0   2.6
Other current assets 25.2   25.2   4.4
Total current assets 371.5   371.5   9.1
Property, plant and equipment, net 0.1   0.1   0.1
Investment in CyrusOne 0   0   0
Goodwill and intangibles, net 0   0   0
Investments in and advances to subsidiaries 1,240.3   1,240.3   1,406.6
Other noncurrent assets 279.0   279.0   359.1
Total assets 1,890.9   1,890.9   1,774.9
Current portion of long-term debt 5.4   5.4   5.4
Accounts payable 0.3   0.3   1.5
Other current liabilities 68.4   68.4   67.7
Total current liabilities 74.1   74.1   74.6
Long-term debt, less current portion 1,874.2   1,874.2   1,916.1
Other noncurrent liabilities 197.8   197.8   214.5
Intercompany payables 300.8   300.8   246.4
Total liabilities 2,446.9   2,446.9   2,451.6
Shareowners' (deficit) equity (556.0)   (556.0)   (676.7)
Total liabilities and shareowners' equity (deficit) 1,890.9   1,890.9   1,774.9
Condensed Consolidating Statements of Cash Flows          
Cash flows (used in) provided by operating activities     (15.0) (123.1)  
Capital expenditures     0 0  
Proceeds from Sale of CyrusOne     0    
Dividends received from CyrusOne     0 0  
Proceeds from sale of assets     0 0  
Cash divested from deconsolidation of CyrusOne       0  
Other investing activities     (0.2) 0  
Cash flows used in investing activities     (0.2) 0  
Funding between Parent and subsidiaries, net     404.7 115.0  
Borrowings on revolving facilities, net     (40.0) 8.0  
Repayment of debt     (2.7) 0  
Proceeds from exercise of options and warrants     1.2 6.6  
Other financing activities     (5.8) (7.0)  
Cash flows provided by (used in) financing activities     357.4 122.6  
(Decrease) increase in cash and cash equivalents     342.2 (0.5)  
Cash and cash equivalents at beginning of period     2.1 3.8  
Cash and cash equivalents at end of period 344.3 3.3 344.3 3.3  
Notes guaranteed by parent [Member] | Cincinnati Bell Telephone Company [Member]
          
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income          
Revenue 164.3 161.6 327.6 320.9  
Operating costs and expenses 115.7 113.6 228.6 224.7  
Operating (loss) income 48.6 48.0 99.0 96.2  
Interest expense (income), net (1.0) (5.6) (1.8) (1.1)  
Other (income) expense, net 2.0 0.9 3.9 2.6  
Income (loss) before equity in earnings of subsidiaries and income taxes 47.6 52.7 96.9 94.7  
Income tax expense (benefit) 17.3 18.3 35.4 34.8  
Equity in earnings of subsidiaries, net of tax 0 0 0 0  
Net income (loss) 30.3 34.4 61.5 59.9  
Other comprehensive income (loss) 0 0 0 0  
Total comprehensive income (loss) 30.3 34.4 61.5 59.9  
Preferred stock dividends 0 0 0 0  
Net income (loss) applicable to common shareowners 30.3 34.4 61.5 59.9  
Condensed Consolidating Balance Sheets          
Cash and cash equivalents 1.8 1.3 1.8 1.3  
Receivables, net 0   0   0
Other current assets 24.2   24.2   24.1
Total current assets 26.0   26.0   25.9
Property, plant and equipment, net 718.8   718.8   706.5
Investment in CyrusOne 0   0   0
Goodwill and intangibles, net 2.2   2.2   2.3
Investments in and advances to subsidiaries 309.4   309.4   247.7
Other noncurrent assets 5.5   5.5   6.1
Total assets 1,061.9   1,061.9   988.5
Current portion of long-term debt 3.5   3.5   3.9
Accounts payable 56.1   56.1   45.9
Other current liabilities 51.4   51.4   49.4
Total current liabilities 111.0   111.0   99.2
Long-term debt, less current portion 139.7   139.7   141.8
Other noncurrent liabilities 174.4   174.4   172.2
Intercompany payables 0   0   0
Total liabilities 425.1   425.1   413.2
Shareowners' (deficit) equity 636.8   636.8   575.3
Total liabilities and shareowners' equity (deficit) 1,061.9   1,061.9   988.5
Condensed Consolidating Statements of Cash Flows          
Cash flows (used in) provided by operating activities     120.9 106.6  
Capital expenditures     (57.4) (69.3)  
Proceeds from Sale of CyrusOne     0    
Dividends received from CyrusOne     0 0  
Proceeds from sale of assets     0.2 1.6  
Cash divested from deconsolidation of CyrusOne       0  
Other investing activities     0 0  
Cash flows used in investing activities     (57.2) (67.7)  
Funding between Parent and subsidiaries, net     (61.7) (37.9)  
Borrowings on revolving facilities, net     0 0  
Repayment of debt     (2.0) (1.6)  
Proceeds from exercise of options and warrants     0 0  
Other financing activities     0 0  
Cash flows provided by (used in) financing activities     (63.7) (39.5)  
(Decrease) increase in cash and cash equivalents     0 (0.6)  
Cash and cash equivalents at beginning of period     1.8 1.9  
Cash and cash equivalents at end of period 1.8 1.3 1.8 1.3  
Notes guaranteed by parent [Member] | Non-Guarantor Subsidiaries [Member]
          
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income          
Revenue 170.0 164.4 343.6 344.9  
Operating costs and expenses 178.2 152.0 339.2 325.4  
Operating (loss) income (8.2) 12.4 4.4 19.5  
Interest expense (income), net 3.8 4.7 7.8 12.3  
Other (income) expense, net (191.9) 4.2 (193.4) 4.5  
Income (loss) before equity in earnings of subsidiaries and income taxes 179.9 3.5 190.0 2.7  
Income tax expense (benefit) 64.7 (1.3) 67.6 8.7  
Equity in earnings of subsidiaries, net of tax 0 0 0 0  
Net income (loss) 115.2 4.8 122.4 (6.0)  
Other comprehensive income (loss) 0 0.1 0 (0.1)  
Total comprehensive income (loss) 115.2 4.9 122.4 (6.1)  
Preferred stock dividends 0 0 0 0  
Net income (loss) applicable to common shareowners 115.2 4.8 122.4 (6.0)  
Condensed Consolidating Balance Sheets          
Cash and cash equivalents 1.1 0.9 1.1 0.9  
Receivables, net 168.0   168.0   152.2
Other current assets 42.0   42.0   63.9
Total current assets 211.1   211.1   216.8
Property, plant and equipment, net 155.8   155.8   196.2
Investment in CyrusOne 290.7   290.7   471.0
Goodwill and intangibles, net 102.7   102.7   103.8
Investments in and advances to subsidiaries 139.8   139.8   0
Other noncurrent assets 168.4   168.4   178.9
Total assets 1,068.5   1,068.5   1,166.7
Current portion of long-term debt 3.2   3.2   3.3
Accounts payable 49.0   49.0   42.5
Other current liabilities 33.3   33.3   34.6
Total current liabilities 85.5   85.5   80.4
Long-term debt, less current portion 200.3   200.3   194.7
Other noncurrent liabilities 30.8   30.8   59.0
Intercompany payables 0   0   199.7
Total liabilities 316.6   316.6   533.8
Shareowners' (deficit) equity 751.9   751.9   632.9
Total liabilities and shareowners' equity (deficit) 1,068.5   1,068.5   1,166.7
Condensed Consolidating Statements of Cash Flows          
Cash flows (used in) provided by operating activities     (12.1) 45.9  
Capital expenditures     (18.1) (26.6)  
Proceeds from Sale of CyrusOne     355.9    
Dividends received from CyrusOne     16.4 7.0  
Proceeds from sale of assets     1.8 0  
Cash divested from deconsolidation of CyrusOne       (12.2)  
Other investing activities     (5.5) 0.4  
Cash flows used in investing activities     350.5 (31.4)  
Funding between Parent and subsidiaries, net     (343.0) (77.1)  
Borrowings on revolving facilities, net     8.6 48.8  
Repayment of debt     (3.6) (3.2)  
Proceeds from exercise of options and warrants     0 0  
Other financing activities     0 0  
Cash flows provided by (used in) financing activities     (338.0) (31.5)  
(Decrease) increase in cash and cash equivalents     0.4 (17.0)  
Cash and cash equivalents at beginning of period     0.7 17.9  
Cash and cash equivalents at end of period 1.1 0.9 1.1 0.9  
Notes guaranteed by parent [Member] | Consolidation, Eliminations [Member]
          
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income          
Revenue (14.4) (14.0) (28.8) (28.1)  
Operating costs and expenses (14.4) (14.0) (28.8) (28.1)  
Operating (loss) income 0 0 0 0  
Interest expense (income), net 0 0 0 0  
Other (income) expense, net 0 0 0 0  
Income (loss) before equity in earnings of subsidiaries and income taxes 0 0 0 0  
Income tax expense (benefit) 0 0 0 0  
Equity in earnings of subsidiaries, net of tax (145.5) (39.2) (183.9) (53.9)  
Net income (loss) (145.5) (39.2) (183.9) (53.9)  
Other comprehensive income (loss) 0 0 0 0  
Total comprehensive income (loss) (145.5) (39.2) (183.9) (53.9)  
Preferred stock dividends 0 0 0 0  
Net income (loss) applicable to common shareowners (145.5) (39.2) (183.9) (53.9)  
Condensed Consolidating Balance Sheets          
Cash and cash equivalents 0 0 0 0  
Receivables, net 0   0   0
Other current assets (0.3)   (0.3)   (0.7)
Total current assets (0.3)   (0.3)   (0.7)
Property, plant and equipment, net 0   0   0
Investment in CyrusOne 0   0   0
Goodwill and intangibles, net 0   0   0
Investments in and advances to subsidiaries (1,689.5)   (1,689.5)   (1,654.3)
Other noncurrent assets (154.6)   (154.6)   (167.8)
Total assets (1,844.4)   (1,844.4)   (1,822.8)
Current portion of long-term debt 0   0   0
Accounts payable 0   0   0
Other current liabilities 0   0   0.1
Total current liabilities 0   0   0.1
Long-term debt, less current portion 0   0   0
Other noncurrent liabilities (154.9)   (154.9)   (168.6)
Intercompany payables (300.8)   (300.8)   (446.1)
Total liabilities (455.7)   (455.7)   (614.6)
Shareowners' (deficit) equity (1,388.7)   (1,388.7)   (1,208.2)
Total liabilities and shareowners' equity (deficit) (1,844.4)   (1,844.4)   (1,822.8)
Condensed Consolidating Statements of Cash Flows          
Cash flows (used in) provided by operating activities     0 0  
Capital expenditures     0 0  
Proceeds from Sale of CyrusOne     0    
Dividends received from CyrusOne     0 0  
Proceeds from sale of assets     0 0  
Cash divested from deconsolidation of CyrusOne       0  
Other investing activities     0 0  
Cash flows used in investing activities     0 0  
Funding between Parent and subsidiaries, net     0 0  
Borrowings on revolving facilities, net     0 0  
Repayment of debt     0 0  
Proceeds from exercise of options and warrants     0 0  
Other financing activities     0 0  
Cash flows provided by (used in) financing activities     0 0  
(Decrease) increase in cash and cash equivalents     0 0  
Cash and cash equivalents at beginning of period     0 0  
Cash and cash equivalents at end of period 0 0 0 0  
Notes guaranteed by subsidiaries [Member]
          
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income          
Revenue 319.9 312.0 642.4 637.7  
Operating costs and expenses 284.3 265.2 549.9 571.7  
Operating (loss) income 35.6 46.8 92.5 66.0  
Interest expense (income), net 40.7 45.4 81.0 93.3  
Other (income) expense, net (190.3) 4.8 (190.2) 6.4  
Income (loss) before equity in earnings of subsidiaries and income taxes 185.2 (3.4) 201.7 (33.7)  
Income tax expense (benefit) 71.0 (4.2) 80.5 2.2  
Equity in earnings of subsidiaries, net of tax 0 0 0 0  
Net income (loss) 114.2 0.8 121.2 (35.9)  
Other comprehensive income (loss) 0.6 9.0 2.4 11.6  
Total comprehensive income (loss) 114.8 9.8 123.6 (24.3)  
Preferred stock dividends 2.6 2.6 5.2 5.2  
Net income (loss) applicable to common shareowners 111.6 (1.8) 116.0 (41.1)  
Condensed Consolidating Balance Sheets          
Cash and cash equivalents 347.2 5.5 347.2 5.5  
Receivables, net 170.0   170.0   154.8
Other current assets 91.1   91.1   91.7
Total current assets 608.3   608.3   251.1
Property, plant and equipment, net 874.7   874.7   902.8
Investment in CyrusOne 290.7   290.7   471.0
Goodwill and intangibles, net 104.9   104.9   106.1
Investments in and advances to subsidiaries 0   0   0
Other noncurrent assets 298.3   298.3   376.3
Total assets 2,176.9   2,176.9   2,107.3
Current portion of long-term debt 12.1   12.1   12.6
Accounts payable 105.4   105.4   89.9
Other current liabilities 153.1   153.1   151.8
Total current liabilities 270.6   270.6   254.3
Long-term debt, less current portion 2,214.2   2,214.2   2,252.6
Other noncurrent liabilities 248.1   248.1   277.1
Intercompany payables 0   0   0
Total liabilities 2,732.9   2,732.9   2,784.0
Shareowners' (deficit) equity (556.0)   (556.0)   (676.7)
Total liabilities and shareowners' equity (deficit) 2,176.9   2,176.9   2,107.3
Condensed Consolidating Statements of Cash Flows          
Cash flows (used in) provided by operating activities     93.8 29.4  
Capital expenditures     (75.5) (95.9)  
Proceeds from Sale of CyrusOne     355.9    
Dividends received from CyrusOne     16.4 7.0  
Proceeds from sale of assets     2.0 1.6  
Cash divested from deconsolidation of CyrusOne       (12.2)  
Other investing activities     (5.7) 0.4  
Cash flows used in investing activities     293.1 (99.1)  
Funding between Parent and subsidiaries, net     0 0  
Borrowings on revolving facilities, net     (31.4) 56.8  
Repayment of debt     (8.3) (4.8)  
Proceeds from exercise of options and warrants     1.2 6.6  
Other financing activities     (5.8) (7.0)  
Cash flows provided by (used in) financing activities     (44.3) 51.6  
(Decrease) increase in cash and cash equivalents     342.6 (18.1)  
Cash and cash equivalents at beginning of period     4.6 23.6  
Cash and cash equivalents at end of period 347.2 5.5 347.2 5.5  
Notes guaranteed by subsidiaries [Member] | Parent Company [Member]
          
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income          
Revenue 0 0 0 0  
Operating costs and expenses 4.8 13.6 10.9 49.7  
Operating (loss) income (4.8) (13.6) (10.9) (49.7)  
Interest expense (income), net 37.9 46.3 75.0 82.1  
Other (income) expense, net (0.4) (0.3) (0.7) (0.7)  
Income (loss) before equity in earnings of subsidiaries and income taxes (42.3) (59.6) (85.2) (131.1)  
Income tax expense (benefit) (11.0) (21.2) (22.5) (41.3)  
Equity in earnings of subsidiaries, net of tax 145.5 39.2 183.9 53.9  
Net income (loss) 114.2 0.8 121.2 (35.9)  
Other comprehensive income (loss) 0.6 8.9 2.4 11.7  
Total comprehensive income (loss) 114.8 9.7 123.6 (24.2)  
Preferred stock dividends 2.6 2.6 5.2 5.2  
Net income (loss) applicable to common shareowners 111.6 (1.8) 116.0 (41.1)  
Condensed Consolidating Balance Sheets          
Cash and cash equivalents 344.3 3.3 344.3 3.3  
Receivables, net 2.0   2.0   2.6
Other current assets 25.2   25.2   4.4
Total current assets 371.5   371.5   9.1
Property, plant and equipment, net 0.1   0.1   0.1
Investment in CyrusOne 0   0   0
Goodwill and intangibles, net 0   0   0
Investments in and advances to subsidiaries 1,240.3   1,240.3   1,406.6
Other noncurrent assets 279.0   279.0   359.1
Total assets 1,890.9   1,890.9   1,774.9
Current portion of long-term debt 5.4   5.4   5.4
Accounts payable 0.3   0.3   1.5
Other current liabilities 68.4   68.4   67.7
Total current liabilities 74.1   74.1   74.6
Long-term debt, less current portion 1,874.2   1,874.2   1,916.1
Other noncurrent liabilities 197.8   197.8   214.5
Intercompany payables 300.8   300.8   246.4
Total liabilities 2,446.9   2,446.9   2,451.6
Shareowners' (deficit) equity (556.0)   (556.0)   (676.7)
Total liabilities and shareowners' equity (deficit) 1,890.9   1,890.9   1,774.9
Condensed Consolidating Statements of Cash Flows          
Cash flows (used in) provided by operating activities     (15.0) (123.1)  
Capital expenditures     0 0  
Proceeds from Sale of CyrusOne     0    
Dividends received from CyrusOne     0 0  
Proceeds from sale of assets     0 0  
Cash divested from deconsolidation of CyrusOne       0  
Other investing activities     (0.2) 0  
Cash flows used in investing activities     (0.2) 0  
Funding between Parent and subsidiaries, net     404.7 115.0  
Borrowings on revolving facilities, net     (40.0) 8.0  
Repayment of debt     (2.7) 0  
Proceeds from exercise of options and warrants     1.2 6.6  
Other financing activities     (5.8) (7.0)  
Cash flows provided by (used in) financing activities     357.4 122.6  
(Decrease) increase in cash and cash equivalents     342.2 (0.5)  
Cash and cash equivalents at beginning of period     2.1 3.8  
Cash and cash equivalents at end of period 344.3 3.3 344.3 3.3  
Notes guaranteed by subsidiaries [Member] | Guarantor Subsidiaries [Member]
          
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income          
Revenue 183.2 177.6 370.3 353.3  
Operating costs and expenses 190.3 163.5 363.2 333.6  
Operating (loss) income (7.1) 14.1 7.1 19.7  
Interest expense (income), net 3.4 3.8 7.0 7.7  
Other (income) expense, net (186.5) 4.2 (183.0) 8.9  
Income (loss) before equity in earnings of subsidiaries and income taxes 176.0 6.1 183.1 3.1  
Income tax expense (benefit) 62.8 (0.7) 65.1 8.8  
Equity in earnings of subsidiaries, net of tax 0 0 0 0.7  
Net income (loss) 113.2 6.8 118.0 (5.0)  
Other comprehensive income (loss) 0 0 0 0  
Total comprehensive income (loss) 113.2 6.8 118.0 (5.0)  
Preferred stock dividends 0 0 0 0  
Net income (loss) applicable to common shareowners 113.2 6.8 118.0 (5.0)  
Condensed Consolidating Balance Sheets          
Cash and cash equivalents 0.6 0.7 0.6 0.7  
Receivables, net 6.0   6.0   7.2
Other current assets 37.9   37.9   60.7
Total current assets 44.5   44.5   68.2
Property, plant and equipment, net 155.4   155.4   194.1
Investment in CyrusOne 290.7   290.7   471.0
Goodwill and intangibles, net 102.7   102.7   103.8
Investments in and advances to subsidiaries 178.0   178.0   (1.6)
Other noncurrent assets 169.5   169.5   179.9
Total assets 940.8   940.8   1,015.4
Current portion of long-term debt 3.2   3.2   3.0
Accounts payable 59.2   59.2   72.3
Other current liabilities 36.7   36.7   36.9
Total current liabilities 99.1   99.1   112.2
Long-term debt, less current portion 85.6   85.6   87.0
Other noncurrent liabilities 33.3   33.3   61.3
Intercompany payables 0   0   149.9
Total liabilities 218.0   218.0   410.4
Shareowners' (deficit) equity 722.8   722.8   605.0
Total liabilities and shareowners' equity (deficit) 940.8   940.8   1,015.4
Condensed Consolidating Statements of Cash Flows          
Cash flows (used in) provided by operating activities     (17.5) 13.1  
Capital expenditures     (18.1) (18.9)  
Proceeds from Sale of CyrusOne     355.9    
Dividends received from CyrusOne     16.4 7.0  
Proceeds from sale of assets     0 0  
Cash divested from deconsolidation of CyrusOne       0  
Other investing activities     (5.5) 0  
Cash flows used in investing activities     348.7 (11.9)  
Funding between Parent and subsidiaries, net     (329.5) 1.5  
Borrowings on revolving facilities, net     0 0  
Repayment of debt     (1.4) (2.3)  
Proceeds from exercise of options and warrants     0 0  
Other financing activities     0 0  
Cash flows provided by (used in) financing activities     (330.9) (0.8)  
(Decrease) increase in cash and cash equivalents     0.3 0.4  
Cash and cash equivalents at beginning of period     0.3 0.3  
Cash and cash equivalents at end of period 0.6 0.7 0.6 0.7  
Notes guaranteed by subsidiaries [Member] | Non-Guarantor Subsidiaries [Member]
          
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income          
Revenue 151.1 148.4 300.9 312.5  
Operating costs and expenses 103.6 102.1 204.6 216.5  
Operating (loss) income 47.5 46.3 96.3 96.0  
Interest expense (income), net (0.6) (4.7) (1.0) 3.5  
Other (income) expense, net (3.4) 0.9 (6.5) (1.8)  
Income (loss) before equity in earnings of subsidiaries and income taxes 51.5 50.1 103.8 94.3  
Income tax expense (benefit) 19.2 17.7 37.9 34.7  
Equity in earnings of subsidiaries, net of tax 0 0 0 0  
Net income (loss) 32.3 32.4 65.9 59.6  
Other comprehensive income (loss) 0 0.1 0 (0.1)  
Total comprehensive income (loss) 32.3 32.5 65.9 59.5  
Preferred stock dividends 0 0 0 0  
Net income (loss) applicable to common shareowners 32.3 32.4 65.9 59.6  
Condensed Consolidating Balance Sheets          
Cash and cash equivalents 2.3 1.5 2.3 1.5  
Receivables, net 162.0   162.0   145.0
Other current assets 28.3   28.3   27.3
Total current assets 192.6   192.6   174.5
Property, plant and equipment, net 719.2   719.2   708.6
Investment in CyrusOne 0   0   0
Goodwill and intangibles, net 2.2   2.2   2.3
Investments in and advances to subsidiaries 294.7   294.7   218.2
Other noncurrent assets 4.4   4.4   5.1
Total assets 1,213.1   1,213.1   1,108.7
Current portion of long-term debt 3.5   3.5   4.2
Accounts payable 45.9   45.9   16.1
Other current liabilities 48.0   48.0   47.1
Total current liabilities 97.4   97.4   67.4
Long-term debt, less current portion 254.4   254.4   249.5
Other noncurrent liabilities 171.9   171.9   169.9
Intercompany payables 36.2   36.2   33.2
Total liabilities 559.9   559.9   520.0
Shareowners' (deficit) equity 653.2   653.2   588.7
Total liabilities and shareowners' equity (deficit) 1,213.1   1,213.1   1,108.7
Condensed Consolidating Statements of Cash Flows          
Cash flows (used in) provided by operating activities     126.3 139.4  
Capital expenditures     (57.4) (77.0)  
Proceeds from Sale of CyrusOne     0    
Dividends received from CyrusOne     0 0  
Proceeds from sale of assets     2.0 1.6  
Cash divested from deconsolidation of CyrusOne       (12.2)  
Other investing activities     0 (0.4)  
Cash flows used in investing activities     (55.4) (87.2)  
Funding between Parent and subsidiaries, net     (75.2) (116.5)  
Borrowings on revolving facilities, net     8.6 48.8  
Repayment of debt     (4.2) (2.5)  
Proceeds from exercise of options and warrants     0 0  
Other financing activities     0 0  
Cash flows provided by (used in) financing activities     (70.8) (70.2)  
(Decrease) increase in cash and cash equivalents     0.1 (18.0)  
Cash and cash equivalents at beginning of period     2.2 19.5  
Cash and cash equivalents at end of period 2.3 1.5 2.3 1.5  
Notes guaranteed by subsidiaries [Member] | Consolidation, Eliminations [Member]
          
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income          
Revenue (14.4) (14.0) (28.8) (28.1)  
Operating costs and expenses (14.4) (14.0) (28.8) (28.1)  
Operating (loss) income 0 0 0 0  
Interest expense (income), net 0 0 0 0  
Other (income) expense, net 0 0 0 0  
Income (loss) before equity in earnings of subsidiaries and income taxes 0 0 0 0  
Income tax expense (benefit) 0 0 0 0  
Equity in earnings of subsidiaries, net of tax (145.5) (39.2) (183.9) (54.6)  
Net income (loss) (145.5) (39.2) (183.9) (54.6)  
Other comprehensive income (loss) 0 0 0 0  
Total comprehensive income (loss) (145.5) (39.2) (183.9) (54.6)  
Preferred stock dividends 0 0 0 0  
Net income (loss) applicable to common shareowners (145.5) (39.2) (183.9) (54.6)  
Condensed Consolidating Balance Sheets          
Cash and cash equivalents 0 0 0 0  
Receivables, net 0   0   0
Other current assets (0.3)   (0.3)   (0.7)
Total current assets (0.3)   (0.3)   (0.7)
Property, plant and equipment, net 0   0   0
Investment in CyrusOne 0   0   0
Goodwill and intangibles, net 0   0   0
Investments in and advances to subsidiaries (1,713.0)   (1,713.0)   (1,623.2)
Other noncurrent assets (154.6)   (154.6)   (167.8)
Total assets (1,867.9)   (1,867.9)   (1,791.7)
Current portion of long-term debt 0   0   0
Accounts payable 0   0   0
Other current liabilities 0   0   0.1
Total current liabilities 0   0   0.1
Long-term debt, less current portion 0   0   0
Other noncurrent liabilities (154.9)   (154.9)   (168.6)
Intercompany payables (337.0)   (337.0)   (429.5)
Total liabilities (491.9)   (491.9)   (598.0)
Shareowners' (deficit) equity (1,376.0)   (1,376.0)   (1,193.7)
Total liabilities and shareowners' equity (deficit) (1,867.9)   (1,867.9)   (1,791.7)
Condensed Consolidating Statements of Cash Flows          
Cash flows (used in) provided by operating activities     0 0  
Capital expenditures     0 0  
Proceeds from Sale of CyrusOne     0    
Dividends received from CyrusOne     0 0  
Proceeds from sale of assets     0 0  
Cash divested from deconsolidation of CyrusOne       0  
Other investing activities     0 0  
Cash flows used in investing activities     0 0  
Funding between Parent and subsidiaries, net     0 0  
Borrowings on revolving facilities, net     0 0  
Repayment of debt     0 0  
Proceeds from exercise of options and warrants     0 0  
Other financing activities     0 0  
Cash flows provided by (used in) financing activities     0 0  
(Decrease) increase in cash and cash equivalents     0 0  
Cash and cash equivalents at beginning of period     0 0  
Cash and cash equivalents at end of period $ 0 $ 0 $ 0 $ 0